Results
|
81.
|
|
|
82.
|
|
|
83.
|
|
|
84.
|
|
|
85.
|
|
|
86.
|
|
|
87.
|
|
|
88.
|
|
|
89.
|
|
|
90.
|
Safety and efficacy of CYT387, a JAK1 and JAK2 inhibitor, in myelofibrosis. [electronic resource] by
- Pardanani, A
- Laborde, R R
- Lasho, T L
- Finke, C
- Begna, K
- Al-Kali, A
- Hogan, W J
- Litzow, M R
- Leontovich, A
- Kowalski, M
- Tefferi, A
Producer: 20130809
In:
Leukemia vol. 27
Availability: No items available.
|
|
91.
|
|
|
92.
|
A Phase Ib/II Study of the JAK1 Inhibitor, Itacitinib, plus [electronic resource] by
- Beatty, Gregory L
- Shahda, Safi
- Beck, Thaddeus
- Uppal, Nikhil
- Cohen, Steven J
- Donehower, Ross
- Gabayan, Afshin Eli
- Assad, Albert
- Switzky, Julie
- Zhen, Huiling
- Von Hoff, Daniel D
Producer: 20200324
In:
The oncologist vol. 24
Availability: No items available.
|
|
93.
|
|
|
94.
|
|
|
95.
|
|
|
96.
|
|
|
97.
|
|
|
98.
|
Structure-based design and development of (benz)imidazole pyridones as JAK1-selective kinase inhibitors. [electronic resource] by
- Simov, Vladimir
- Deshmukh, Sujal V
- Dinsmore, Christopher J
- Elwood, Fiona
- Fernandez, Rafael B
- Garcia, Yudith
- Gibeau, Craig
- Gunaydin, Hakan
- Jung, Joon
- Katz, Jason D
- Kraybill, Brian
- Lapointe, Blair
- Patel, Sangita B
- Siu, Tony
- Su, Hua
- Young, Jonathan R
Producer: 20161107
In:
Bioorganic & medicinal chemistry letters vol. 26
Availability: No items available.
|
|
99.
|
|
|
100.
|
|